<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Analyst initiations: AMAG, CPO and ALO]]></title><link>http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/</guid><comments>http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/bax/" rel="tag">Baxter Intl (BAX)</a>, <a href="http://www.bloggingstocks.com/category/analyst-initiations/" rel="tag">Analyst Initiations</a></p><strong><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2008/02/fly-logo-(aol).gif" /></a>MOST NOTEWORTHY:</strong> Amag Pharmaceuticals, Corn Products and Alpharma were today's noteworthy initiations: <br />
<ul>
    <li>Baird initiated Amag Pharmaceuticals (NASDAQ: AMAG) with an Outperform rating and believes concerns regarding ferumoxytol approvability are misplaced. </li>
    <li>JP Morgan assumed coverage of Corn Products (NYSE: CPO) with an Overweight rating and points to the company's growth in emerging markets and improved business economics in its core U.S. market. </li>
    <li>RBC Capital is positive on Alpharma's (NYSE: ALO) Flector opportunity in the U.S. topical NSAID market. The firm started shares with an Outperform rating and $28 target.</li>
</ul>
<strong>OTHER INITIATIONS: </strong><br />
<ul>
    <li>Merrill resumed coverage of Baxter (NYSE: BAX) with a Buy rating. </li>
    <li>Goldman initiated Teradyne (NYSE: TER) with a Neutral rating and $11 target. </li>
    <li>Allianz AG (NYSE: AZ) was initiated with a Buy rating at Societe Generale.</li>
</ul><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/">Analyst initiations: AMAG, CPO and ALO</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 04 Feb 2008 10:50:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1105800/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/02/04/analyst-initiations-amag-cpo-and-alo/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Allianz AG</category><category>AllianzAg</category><category>ALO</category><category>Alpharma</category><category>AMAG</category><category>Amag Pharmaceuticals</category><category>AmagPharmaceuticals</category><category>AZ</category><category>BAX</category><category>Baxter</category><category>Baxter International</category><category>BaxterInternational</category><category>Corn Products</category><category>CornProducts</category><category>CPO</category><category>initiations</category><category>TER</category><category>Teradyne</category><dc:creator><![CDATA[Laurie Pasternack]]></dc:creator><pubDate>Mon, 04 Feb 2008 10:50:00 EST</pubDate></item></channel></rss>
